NOVL, created in 2014 (United States), from 39 sister brands and 4472 competing brands. NOVL is a brand of Haemonetics Co., listed on the stock exchange of New York. NOVL belongs to the Medical Devices & Instruments business sector.
Investment simulator :
Portfolio valuation
Haemonetics Co.
(NOVL)
over 5 years*
USD 91.64